Cipla faces downgrade after USFDA warning letter
B&K Securities airs concerns considering Cipla’s significant exposure to the US market, constituting 28% of consolidated sales
Source: businesstoday.in
Cipla Pithampur News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cipla Pithampur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cipla Pithampur Today - Breaking & Trending Today
Stocks in news: Tata Steel, IndiGo, Welspun Corp, Cipla, Mamaearth
Walchandnagar Ind said there is a strike by the labour union at Walchandnagar unit and operations are partially affected. There is no strike at Maharashtra, Dharwad plants.
Source: indiatimes.com
US FDA plant observations at Cipla cause 6-month delay in product launches: CEO
The biggest product under manufacture in the Pithampur facility is Advair which has a market size of $700 million
Source: moneycontrol.com
Cipla Q1 Preview: Steady earnings expected, strong India growth to offset subdued US sales
Most brokerages see Cipla as the frontrunner of growth within the domestic market in Q1 which will help offset the adverse impact of a moderation in US sales.
Source: moneycontrol.com
USFDA issues 8 observations for Cipla's Pithampur manufacturing facility
USFDA conducted a Good Manufacturing Practices (cGMP) inspection at Cipla's Pithampur manufacturing facility from 6-17 February, 2023.
Source: livemint.com